Appointment of Dean of Ernest Mario School of Pharmacy

October 1, 2007

Members of the Rutgers Community:

It is my pleasure to announce the appointment of Christopher J. Molloy, Ph.D., R.Ph., as dean of the Ernest Mario School of Pharmacy (EMSP), effective October 22, 2007. Dr. Molloy will succeed Dean John Colaizzi, who will return to the faculty after his long and truly outstanding tenure as dean.

Dr. Molloy comes to Rutgers from Johnson & Johnson Pharmaceutical Research and Development L.L.C., where he served as senior research fellow and team leader in the East Coast Research and Early Development unit. In this capacity, he provided strategic leadership and day-to-day management of a preclinical drug discovery research group, which focused on the molecular mechanisms of inflammation, oncology, fibrosis, and pulmonary diseases. He was also discovery project leader for several compounds progressing in human clinical trials and advanced medicinal chemistry programs. Before joining Johnson & Johnson in 2003, Dr. Molloy held positions with 3-Dimensional Pharmaceuticals, Inc. and the Bristol-Myers Squibb Pharmaceutical Research Institute. He has been a New Jersey registered pharmacist since 1977.

A graduate of the Rutgers College of Pharmacy, Dr. Molloy earned his Ph.D. in toxicology from the Rutgers University Graduate School and the Graduate School of Biomedical Sciences, UMDNJ. He was a post-doctoral fellow at the National Cancer Institute, National Institutes of Health. Dr. Molloy has conducted research in receptor agonists, growth factors, and molecular mechanisms of signal transduction that resulted in extensive publications in scientific journals as well as issued patents. More details on his research interests and achievements are contained in the news release at http://urwebsrv.rutgers.edu/medrel/viewArticle.html?ArticleID=5972.

The members of the dean search committee, chaired by Professor Kathryn Uhrich, have my sincere thanks for their dedicated work, which has produced an excellent result. Dr. Molloy's vast experience in drug development processes, his broad understanding of New Jersey's pharmaceutical industry, his deep commitment to pharmacy education that encompasses both clinical practice and basic pharmaceutical research, and his scholarly contributions to medicinal chemistry, cell biology, and drug discovery and design make him the ideal person to lead the Ernest Mario School of Pharmacy into the future.

Please join me in welcoming Dean Molloy to the EMSP and to the Rutgers community.

Richard L. McCormick
President
Rutgers, The State University of New Jersey